Cargando…
Risk factors for COVID-19 mortality in hospitalized patients in Bolivia
OBJECTIVES: This study aimed to ascertain which factors are associated with higher risk of mortality among hospitalized COVID-19 Bolivian patients. METHODS: This retrospective observational study assessed risk factors associated with mortality in patients (n = 549) hospitalized for SARS-CoV-2 infect...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643226/ https://www.ncbi.nlm.nih.gov/pubmed/38020182 http://dx.doi.org/10.1016/j.ijregi.2023.10.002 |
_version_ | 1785134309958483968 |
---|---|
author | Limachi-Choque, Jhonny Guitian, Javier Leyns, Christine Guzman-Rivero, Miguel Eid, Daniel |
author_facet | Limachi-Choque, Jhonny Guitian, Javier Leyns, Christine Guzman-Rivero, Miguel Eid, Daniel |
author_sort | Limachi-Choque, Jhonny |
collection | PubMed |
description | OBJECTIVES: This study aimed to ascertain which factors are associated with higher risk of mortality among hospitalized COVID-19 Bolivian patients. METHODS: This retrospective observational study assessed risk factors associated with mortality in patients (n = 549) hospitalized for SARS-CoV-2 infection in a Bolivian hospital between April 6, 2020, and August 18, 2022. RESULTS: The results provide evidence of association between male sex (odds ratio [OR] = 1.6, 95% confidence interval [CI] 1.06-2.6), older age, 51-61 years-old (OR = 5.2, 95% CI 2.2-12.6), 62-70 years-old (OR = 8.7, 95% CI 3.7-20.5), >70 years-old (OR = 16.9, 95% CI 7.1-39.9), and blood group A (OR = 1.9, 95% CI: 1.1-3.4) with higher mortality risk. The strong association between mortality and relatively young age, may be due to high frequency of undiagnosed comorbidities. Vaccination was associated with a reduction in mortality only when time period of hospitalization was not adjusted for. CONCLUSION: Among hospitalized patients in Bolivia male sex, older age, and blood group A are associated with higher mortality risk. Mortality risk increased markedly from a relatively young age and decreased in parallel to the uptake of the vaccination program. However, the gradual reduction in mortality can also be due to improved patient management and changes in natural immunity and virulence of circulating strains as the pandemic progressed. |
format | Online Article Text |
id | pubmed-10643226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-106432262023-11-01 Risk factors for COVID-19 mortality in hospitalized patients in Bolivia Limachi-Choque, Jhonny Guitian, Javier Leyns, Christine Guzman-Rivero, Miguel Eid, Daniel IJID Reg Original Report OBJECTIVES: This study aimed to ascertain which factors are associated with higher risk of mortality among hospitalized COVID-19 Bolivian patients. METHODS: This retrospective observational study assessed risk factors associated with mortality in patients (n = 549) hospitalized for SARS-CoV-2 infection in a Bolivian hospital between April 6, 2020, and August 18, 2022. RESULTS: The results provide evidence of association between male sex (odds ratio [OR] = 1.6, 95% confidence interval [CI] 1.06-2.6), older age, 51-61 years-old (OR = 5.2, 95% CI 2.2-12.6), 62-70 years-old (OR = 8.7, 95% CI 3.7-20.5), >70 years-old (OR = 16.9, 95% CI 7.1-39.9), and blood group A (OR = 1.9, 95% CI: 1.1-3.4) with higher mortality risk. The strong association between mortality and relatively young age, may be due to high frequency of undiagnosed comorbidities. Vaccination was associated with a reduction in mortality only when time period of hospitalization was not adjusted for. CONCLUSION: Among hospitalized patients in Bolivia male sex, older age, and blood group A are associated with higher mortality risk. Mortality risk increased markedly from a relatively young age and decreased in parallel to the uptake of the vaccination program. However, the gradual reduction in mortality can also be due to improved patient management and changes in natural immunity and virulence of circulating strains as the pandemic progressed. Elsevier 2023-11-01 /pmc/articles/PMC10643226/ /pubmed/38020182 http://dx.doi.org/10.1016/j.ijregi.2023.10.002 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Report Limachi-Choque, Jhonny Guitian, Javier Leyns, Christine Guzman-Rivero, Miguel Eid, Daniel Risk factors for COVID-19 mortality in hospitalized patients in Bolivia |
title | Risk factors for COVID-19 mortality in hospitalized patients in Bolivia |
title_full | Risk factors for COVID-19 mortality in hospitalized patients in Bolivia |
title_fullStr | Risk factors for COVID-19 mortality in hospitalized patients in Bolivia |
title_full_unstemmed | Risk factors for COVID-19 mortality in hospitalized patients in Bolivia |
title_short | Risk factors for COVID-19 mortality in hospitalized patients in Bolivia |
title_sort | risk factors for covid-19 mortality in hospitalized patients in bolivia |
topic | Original Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643226/ https://www.ncbi.nlm.nih.gov/pubmed/38020182 http://dx.doi.org/10.1016/j.ijregi.2023.10.002 |
work_keys_str_mv | AT limachichoquejhonny riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia AT guitianjavier riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia AT leynschristine riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia AT guzmanriveromiguel riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia AT eiddaniel riskfactorsforcovid19mortalityinhospitalizedpatientsinbolivia |